Table 2.
Hazard Ratios for Breast Cancer Specific Mortality, Stratified by Race and Menopausal Status and Adjusted for Age at Diagnosis and Date of Diagnosis
White |
African American |
|||
---|---|---|---|---|
Premenopausal (n=323) | Postmenopausal (n=308) | Premenopausal (n=238) | Postmenopausal (n=280) | |
Subtype | ||||
Luminal A | 1.00 | 1.00 | 1.00 | 1.00 |
Luminal B | 1.2 (0.6, 2.5) | 2.9 (1.0, 8.4) | 1.2 (0.5, 2.9) | 1.3 (0.5, 3.6) |
Basal-like | 1.8 (1.0, 3.4) | 3.9 (1.5, 10.0) | 1.3 (0.8, 2.3) | 1.9 (0.9, 3.8) |
HER2+/ER− | 2.1 (0.9, 5.0) | 4.3 (1.4, 13.6) | 1.9 (0.9, 4.2) | 3.1 (1.3, 7.2) |
Unclassified | 1.4 (0.7, 3.0) | 2.1 (0.6, 7.4) | 1.0 (0.5, 2.0) | 1.9 (0.8, 4.3) |
Subtype combined | ||||
Luminal A or B | 1.00 | 1.00 | 1.00 | 1.00 |
Basal-like | 1.8 (1.0, 3.2) | 3.0 (1.2, 7.4) | 1.3 (0.8, 2.2) | 1.8 (0.9, 3.6) |
HER2+/ER− | 2.0 (0.9, 4.8) | 3.4 (1.1, 10.3) | 1.9 (0.9, 4.0) | 3.0 (1.3, 6.9) |
ER status | ||||
ER+ | 1.00 | 1.00 | 1.00 | 1.00 |
ER− | 1.4 (0.9, 2.2) | 2.1 (1.0, 4.2) | 1.3 (0.8, 2.2) | 2.3 (1.3, 3.9) |
PR status | ||||
PR+ | 1.00 | 1.00 | 1.00 | 1.00 |
PR− | 1.9 (1.2, 3.0) | 2.1 (1.0, 4.2) | 1.4 (0.9, 2.3) | 1.9 (1.1, 3.4) |
HER2 status | ||||
HER2− | 1.00 | 1.00 | 1.00 | 1.00 |
HER2+ | 1.2 (0.7, 2.1) | 2.3 (1.1, 5.1) | 1.4 (0.8, 2.5) | 1.5 (0.8, 2.9) |